Mastropaolo Mariangela, Zizzo Maria Grazia, Auteri Michelangelo, Mulè Flavia, Serio Rosa
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF) Laboratorio di Fisiologia generale, Università di Palermo, Viale delle Scienze, I-90128 Palermo, Italy.
Regul Pept. 2013 Nov 10;187:29-34. doi: 10.1016/j.regpep.2013.10.005. Epub 2013 Oct 31.
The aim of this study was to analyze whether arginine vasopressin (AVP) may be considered a modulator of intestinal motility. In this view, we evaluated, in vitro, the effects induced by exogenous administration of AVP on the contractility of mouse distal colon, the subtype(s) of receptor(s) activated and the action mechanism. Isometric recordings were performed on longitudinal and circular muscle strips of mouse distal colon. AVP (0.001 nM-100 nM) caused concentration-dependent contractile effects only on the longitudinal muscle, antagonized by the V1 receptor antagonist, V-1880. AVP-induced effect was not modified by tetrodotoxin, atropine and indomethacin. Contractile response to AVP was reduced in Ca(2+)-free solution or in the presence of nifedipine, and it was abolished by depletion of calcium intracellular stores after repetitive addition of carbachol in calcium-free medium with addition of cyclopiazonic acid. U-73122, an inhibitor of the phospholipase C, effectively antagonized AVP effects, whilst it was not affected by an adenylyl cyclase inhibitor. Oxytocin induced an excitatory effect in the longitudinal muscle of distal colon at very high concentrations, effect antagonized by V-1880. The results of this study shown that AVP, via activation of V1 receptors, is able to modulate positively contractile activity of longitudinal muscle of mouse distal colon, independently by enteric nerve activation and prostaglandin synthesis. Contractile response is achieved by increase in cytoplasmatic Ca(2+) concentration via extracellular Ca(2+) influx from L-type Ca(2+) channels and via Ca(2+) release from intracellular stores through phospholipase C pathway. No modulation has been observed on the contractility of the circular muscle.
本研究的目的是分析精氨酸加压素(AVP)是否可被视为肠道运动的调节因子。从这一角度出发,我们在体外评估了外源性给予AVP对小鼠远端结肠收缩性、激活的受体亚型以及作用机制所产生的影响。对小鼠远端结肠的纵行和环行肌条进行了等长记录。AVP(0.001 nM - 100 nM)仅对纵行肌产生浓度依赖性收缩效应,可被V1受体拮抗剂V - 1880拮抗。AVP诱导的效应不受河豚毒素、阿托品和吲哚美辛的影响。在无钙溶液或存在硝苯地平的情况下,对AVP的收缩反应降低,并且在无钙培养基中重复添加卡巴胆碱并添加环匹阿尼酸耗尽细胞内钙储备后,该反应被消除。磷脂酶C抑制剂U - 73122有效拮抗AVP的作用,而腺苷酸环化酶抑制剂对其无影响。催产素在非常高的浓度下可诱导远端结肠纵行肌产生兴奋效应,该效应可被V - 1880拮抗。本研究结果表明,AVP通过激活V1受体,能够独立于肠神经激活和前列腺素合成,正向调节小鼠远端结肠纵行肌的收缩活性。收缩反应是通过L型钙通道的细胞外钙内流以及通过磷脂酶C途径从细胞内储存释放钙来增加细胞质钙浓度而实现的。未观察到对环行肌收缩性的调节作用。